NCT00647920View on ClinicalTrials.gov

Study of Adalimumab Administered as Subcutaneous Injections in Adult Chinese Rheumatoid Arthritis Subjects Treated With Methotrexate

PHASE3CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

July 31, 2003

Primary Completion Date

April 30, 2005

Conditions
Rheumatoid Arthritis
Interventions
BIOLOGICAL

adalimumab

40 mg adalimumab sc, every other week

BIOLOGICAL

placebo

placebo sc, every other week

Trial Locations (1)

Unknown

Taichung

Sponsors

Lead Sponsor

Abbott
All Listed Sponsors
lead

Abbott

INDUSTRY